News

January 14, 2022 – BD (Becton, Dickinson and Company) announced the launch and 510(k) clearance from the U.S. Food and Drug Administration of the Crosser iQ™ CTO Recanalization System, which is designed to help physicians cross peripheral...

January 14, 2022 — Up to 60 percent of the risk associated with coronary arteriosclerosis may be explained by changes in the activity of hundreds of genes working together in networks across several organs in the body. Moreover, fat...

SANTA CLARA, Calif.  – JANUARY 14, 2022 – A live vascular ultrasound scanning session at the upcoming ISET 2022 meeting, will utilize  the Avail System to broadcast and showcase ultrasound scanning techniques. Avail’s uniquely immersive...

The statement addresses the gap between existing evidence on how best to lower cardiovascular disease (CVD) risk in people with Type 2 diabetes and the reality for people living with the disease. 

Replacing margarine, butter, mayonnaise and dairy fat with olive oil was associated with lower mortality risk

As the first Medtronic self-expanding TAVR system approved in China, the Evolut PRO system approval is based on clinical data from more than 32,000 patients, which showed high survival, low rates of stroke, minimal paravalvular leak (PVL) and...

Cardiology practices can participate to improve patient access to sleep apnea care

January 7, 2022 — Not too long ago, the idea of taking, for instance a skin cell and transforming it into a muscle cell was unthinkable. About 10 years ago, however, revolutionary research showed that it is indeed possible to reprogram...

A recent international study led by researchers at Massachusetts General Hospital (MGH) and other institutions offers real-world results on the use of a novel device for treating brain aneurysms.

Acting as Both a Dual Protease and TMPRSS2 Inhibitor, Pentarlandir is About to Enter FDA Phase III Trial